ID

40510

Beschrijving

A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS); ODM derived from: https://clinicaltrials.gov/show/NCT01230827

Link

https://clinicaltrials.gov/show/NCT01230827

Trefwoorden

Versies (1)
  1. 28-04-20 28-04-20 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

28 april 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Juvenile Idiopathic Arthritis NCT01230827

Engels

Eligibility Juvenile Idiopathic Arthritis NCT01230827

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis must have been before the patient's 16th birthday
Beschrijving

Diagnosis | Age

Datatype

boolean

Alias
UMLS CUI [1]
C0011900
UMLS CUI [2]
C0001779
disease duration of at least 6 months before study entry
Beschrijving

Disease length

Datatype

boolean

Alias
UMLS CUI [1]
C0872146
must have 5 or more joints with active arthritis
Beschrijving

Arthritis Joints Count

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003864
UMLS CUI [1,2]
C0022417
UMLS CUI [1,3]
C0750480
must be taking a stable dose of methotrexate 10-30 mg/meter squared (patients with body surface area [bsa] 1.67 square meter or more must be taking a minimum of 15 mg/week of methotrexate)
Beschrijving

Methotrexate Dose Stable | Body Surface Area

Datatype

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C0005902
may take a stable dose of prednisone less than 10 mg/day 4 weeks prior to entry or may take a stable dose of nsaids (non-steroidal anti-inflammatory drugs) 2 weeks prior to entry
Beschrijving

Prednisone Dose Stable U/day | NSAIDs Dose Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0032952
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0456683
UMLS CUI [2,1]
C0003211
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
must have qualifying laboratory values at the first visit.
Beschrijving

Laboratory Results Qualifying

Datatype

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C1514624
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
have known allergies, hypersensitivity, or intolerance to golimumab or similar therapeutics
Beschrijving

Hypersensitivity Golimumab | Intolerance to Golimumab | Hypersensitivity Pharmaceutical Preparations Similar | Intolerance to Pharmaceutical Preparations Similar

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2353893
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C2353893
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C2348205
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0013227
UMLS CUI [4,3]
C2348205
are pregnant or breast-feeding, or planning a pregnancy or fathering a child within 6 months after the last study agent administration
Beschrijving

Pregnancy | Breast Feeding | Pregnancy, Planned | Reproduction Planned

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0035150
UMLS CUI [4,2]
C1301732
have initiated dmards and/or immunosuppressive therapy within 4 weeks prior to study initiation
Beschrijving

Initiation DMARDs | Initiation Therapeutic immunosuppression

Datatype

boolean

Alias
UMLS CUI [1,1]
C1704686
UMLS CUI [1,2]
C0242708
UMLS CUI [2,1]
C1704686
UMLS CUI [2,2]
C0021079
Terug naar het begin van de pagina

Similar models

Eligibility Juvenile Idiopathic Arthritis NCT01230827

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosis | Age
Item
diagnosis must have been before the patient's 16th birthday
boolean
C0011900 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Disease length
Item
disease duration of at least 6 months before study entry
boolean
C0872146 (UMLS CUI [1])
Arthritis Joints Count
Item
must have 5 or more joints with active arthritis
boolean
C0003864 (UMLS CUI [1,1])
C0022417 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])
Methotrexate Dose Stable | Body Surface Area
Item
must be taking a stable dose of methotrexate 10-30 mg/meter squared (patients with body surface area [bsa] 1.67 square meter or more must be taking a minimum of 15 mg/week of methotrexate)
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0005902 (UMLS CUI [2])
Prednisone Dose Stable U/day | NSAIDs Dose Stable
Item
may take a stable dose of prednisone less than 10 mg/day 4 weeks prior to entry or may take a stable dose of nsaids (non-steroidal anti-inflammatory drugs) 2 weeks prior to entry
boolean
C0032952 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0003211 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Laboratory Results Qualifying
Item
must have qualifying laboratory values at the first visit.
boolean
C1254595 (UMLS CUI [1,1])
C1514624 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Golimumab | Intolerance to Golimumab | Hypersensitivity Pharmaceutical Preparations Similar | Intolerance to Pharmaceutical Preparations Similar
Item
have known allergies, hypersensitivity, or intolerance to golimumab or similar therapeutics
boolean
C0020517 (UMLS CUI [1,1])
C2353893 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C2353893 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C2348205 (UMLS CUI [3,3])
C1744706 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
Pregnancy | Breast Feeding | Pregnancy, Planned | Reproduction Planned
Item
are pregnant or breast-feeding, or planning a pregnancy or fathering a child within 6 months after the last study agent administration
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0035150 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
Initiation DMARDs | Initiation Therapeutic immunosuppression
Item
have initiated dmards and/or immunosuppressive therapy within 4 weeks prior to study initiation
boolean
C1704686 (UMLS CUI [1,1])
C0242708 (UMLS CUI [1,2])
C1704686 (UMLS CUI [2,1])
C0021079 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial